Supernus Pharmaceuticals Inc (SUPN)
35.47
+0.71
(+2.04%)
USD |
NASDAQ |
Nov 05, 14:48
Supernus Pharmaceuticals 1 Year Total Returns (Daily): 41.99% for Nov. 4, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 04, 2024 | 41.99% |
November 01, 2024 | 42.07% |
October 31, 2024 | 42.85% |
October 30, 2024 | 47.63% |
October 29, 2024 | 45.93% |
October 28, 2024 | 44.99% |
October 25, 2024 | 45.94% |
October 24, 2024 | 40.83% |
October 23, 2024 | 42.55% |
October 22, 2024 | 38.67% |
October 21, 2024 | 38.50% |
October 18, 2024 | 36.90% |
October 17, 2024 | 30.40% |
October 16, 2024 | 31.60% |
October 15, 2024 | 34.94% |
October 14, 2024 | 32.53% |
October 11, 2024 | 21.95% |
October 10, 2024 | 16.68% |
October 09, 2024 | 18.26% |
October 08, 2024 | 18.44% |
October 07, 2024 | 16.84% |
October 04, 2024 | 18.99% |
October 03, 2024 | 18.49% |
October 02, 2024 | 18.58% |
October 01, 2024 | 16.07% |
Date | Value |
---|---|
September 30, 2024 | 13.09% |
September 27, 2024 | 7.59% |
September 26, 2024 | 5.34% |
September 25, 2024 | 4.83% |
September 24, 2024 | 8.52% |
September 23, 2024 | 11.54% |
September 20, 2024 | 15.04% |
September 19, 2024 | 12.97% |
September 18, 2024 | 12.47% |
September 17, 2024 | 8.52% |
September 16, 2024 | 7.70% |
September 13, 2024 | 3.60% |
September 12, 2024 | 0.29% |
September 11, 2024 | 4.37% |
September 10, 2024 | 9.48% |
September 09, 2024 | 10.85% |
September 06, 2024 | 6.85% |
September 05, 2024 | 8.25% |
September 04, 2024 | 7.73% |
September 03, 2024 | 6.83% |
August 30, 2024 | 9.98% |
August 29, 2024 | 10.55% |
August 28, 2024 | 10.71% |
August 27, 2024 | 11.18% |
August 26, 2024 | 11.09% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-62.34%
Minimum
Mar 18 2020
81.11%
Maximum
Mar 17 2021
1.72%
Average
1.86%
Median
1 Year Total Returns (Daily) Benchmarks
ACADIA Pharmaceuticals Inc | -39.26% |
Regeneron Pharmaceuticals Inc | 1.47% |
United Therapeutics Corp | 67.89% |
Ligand Pharmaceuticals Inc | 104.0% |
Myomo Inc | 179.6% |